Discovery and development of antidepressants: A perspective from a pharmaceutical discovery company

Biological Psychiatry

Volumn 52, Issue 3, 2002, Pages 154-156

  Scolnick, Edward M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DRUG METABOLIZING ENZYME; FLUOXETINE; FLUVOXAMINE; NORADRENALIN; PAROXETINE; SEROTONIN; SERTRALINE;

AGING; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG EFFECT; DRUG HALF LIFE; DRUG INDUSTRY; DRUG MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL ASPECT; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; CYTOCHROME P-450 CYP2D6; DRUG INDUSTRY; HUMANS; MENTAL DISORDERS;

EID: 0036669283     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01353-1     Document Type: Conference Paper

References (16)

1. Bartels S.J., Forester B., Miles K.M., Joyce T. Mental health service use by elderly patients with bipolar disorder and unipolar major depression. Am J Geriatr Psychiatry. 8:2000;160-166.
2. Borowsky B., Adham N., Jones K.A., Raddatz R., Artymyshyn R., Ogozalek K.L., et al. Trace amines Identification of a family of mammalian G protein-coupled receptors . Proc Natl Acad Sci USA. 98:2001;8966-8971.
3. Cassidy E.L., Baird E., Sheikh J.I. Recruitment and retention of elderly patients in clinical trials. Am J Geriatr Psychiatry. 9:2001;136-140.
4. European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit . Concept paper on the revision of the Committee for Proprietary Medicinal Products (CPMP) note for guidance on medicinal products for the treatment of depression. 1998;1-4 European Agency for the Evaluation of Medicinal Products, London.
5. Katz I.R. Drug treatment of depression in the frail elderly Discussion of the NIH Consensus Development Conference on the Diagnosis and Treatment of Depression in Late Life . Psychopharmacology Bulletin. 29:1993;101-108.
6. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
7. Lebowitz B.D., Martinez R.A., Niederehe G., Pearson J.L., Reynolds C.F. III, Rudorfer M.V., et al. NIMH/MacArthur Foundation Workshop report. Psychopharmacol Bull. 31:1995;185-202.
8. Lebowitz B.D., Pearson J.L., Schneider L.S., Reynolds C.F. III, Alexopolous G.S., Bruce M.L., et al. Diagnosis and treatment of depression in late life. JAMA. 278:1997;1186-1190.
9. Lenze E.J., Rogers J.C., Martire L.M., Mulsant B.H., Rollman B.L., Dew M.A., et al. The association of late-life depression and anxiety with physical disability. Am J Geriatr Psychiatry. 9:2001;113-135.
10. Luder M.P., Meyers B.S., Williams-Russo P.G., Hollenberg J.P., DiDomenico T.N., Charlson M.E., Alexopoulos G.S. Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry. 9:2001;169-176.
11. National Institutes of Health . Diagnosis and treatment of depression in late life The NIH Consensus Development Conference Statement . Psychopharmacol Bull. 29:1993;87-100.
12. Reynolds C.F. III, Lebowitz B.D., Schneider L.S. Diagnosis and treatment of depression in late life. Psychopharmacol Bull. 29:1993;83-85.
13. Robinson R.G., Schultz S.K., Castillo C., Kopel T., Kosier T., Newman R.M., et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke A placebo-controlled, double-blind study . Am J Psychiatry. 157:2000;351-359.
14. Santarelli L., Gobbi G., Debs P.C., Sibille E.L., Blier P., Hen R., Health M.J.S. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA. 98:2001;1912-1917.
15. Solai L.K., Mulsant B.H., Pollock B.G. Selective serotonin reuptake inhibitors for late-life depression. Drugs Aging. 18:2001;355-368.
16. Williams J.W. Jr, Mulrow C.D., Chiquette E., Noel P.H., Aguilar C., Cornell J. A systematic review of newer pharmacotherapies for depression in adults Evidence report summary . Ann Intern Med. 132:2000;743-756.